Varenicline, a nicotinic receptor agonist for the treatment of Excessive Daytime Sleepiness in Parkinson's Disease: a placebo-controlled cross-over pilot study.

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
E.M.J.
Principal Investigator Last Name
Foncke
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
$31,151
Funding Organization